PARP inhibitors for chemoprevention - Letter

Cancer Prevention Research

Volumn 7, Issue 11, 2014, Pages 1170-1171

  Chand, Saswati N ^a   Blanco, Fernando F ^a,c   Jimbo, Masaya ^a   Tsangaris, Theodore N ^a   Cristofanilli, Massimo ^a   Yeo, Charles J ^a   Winter, Jordan M ^a   Pishvaian, Michael J ^b   Brody, Jonathan R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; GEMCITABINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OLAPARIB; PLATINUM DERIVATIVE; PROTEIN P53; VELIPARIB; ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHTHALAZINE DERIVATIVE; PIPERAZINE DERIVATIVE;

BONE MARROW SUPPRESSION; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; CHEMOPROPHYLAXIS; CHROMOSOMAL INSTABILITY; CLINICAL EVALUATION; DNA REPAIR; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; LETTER; NULL ALLELE; OVARY CANCER; PANCREAS CANCER; WATCHFUL WAITING; ANIMAL; ANTAGONISTS AND INHIBITORS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BRCA1 PROTEIN; FEMALE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; PHTHALAZINES; PIPERAZINES; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84910125631     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0220     Document Type: Letter

References (7)

1. To C, Kim E-H, Royce DB, Williams CR, Collins RM, Risingson R, et al. The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient mice. Cancer Prev Res 2014;7:698-707.
2. Foulkes WD, Shuen AY. In brief: BRCA1 and BRCA2. J Pathol 2013;240:347-9.
3. Fong PC, Boss DS, Yap A, Tutt A, Wu P, Mergui-Roelvnik M, et al. Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Eng J Med 2009;361:123-34.
4. Helleday T. Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice. Curr Opin Oncol 2013;25:609-14.
5. Deng CX, Scott F. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 2000;19:1059-64.
6. Lord CJ, Ashworth A. Mechanisms of resistance to therapies targeting BRCA-mutant cancers. Nat Med 2013;19:1381-8.
7. Weaver AN, Yang ES. Beyond DNA repair: additional functions of PARP-1 in cancer. Front Oncol 2013;3:290.